Revive Therapeutics (XCNQ:RVV) Operating Cash Flow per Share : C$-0.00 (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics Operating Cash Flow per Share?

Revive Therapeutics's operating cash flow per share for the three months ended in Dec. 2023 was C$-0.00. Revive Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Revive Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

XCNQ:RVV' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -29.2 Med: 9.1 Max: 38.6
Current: 9.1

During the past 10 years, Revive Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 38.60% per year. The lowest was -29.20% per year. And the median was 9.10% per year.

XCNQ:RVV's 3-Year OCF Growth Rate is ranked better than
51.81% of 801 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs XCNQ:RVV: 9.10

Revive Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Revive Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Operating Cash Flow per Share Chart

Revive Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.02

-0.03

-0.04

-0.02

Revive Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.01	-	-	-	-

Competitive Comparison of Revive Therapeutics's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Revive Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Revive Therapeutics's Price-to-Operating-Cash-Flow falls into.

Revive Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Revive Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	-6.026	/	339.371
	=	-0.02

Revive Therapeutics's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-0.883	/	357.821
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00

Revive Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics (XCNQ:RVV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

RVVTF:USA 31R:Germany

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.

Executives

Michael Frank

Director, Senior Officer

Revive Therapeutics (XCNQ:RVV) Headlines

No Headlines